ArticleThoracic cancer2022

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.

John Wen-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.